首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1954195

細胞裂解/細胞分級分離市場分析及預測（至2035年）：依類型、產品類型、技術、應用、最終用戶、製程、組件及設備分類

Cell Lysis/Cell Fractionation Market Analysis and Forecast to 2035: Type, Product, Technology, Application, End User, Process, Component, Device

出版日期: 2026年02月11日 | 出版商:

Global Insight Services | 英文 392 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

細胞裂解/細胞分級分離市場預計將從2024年的45億美元成長到2034年的80億美元，複合年成長率約為5%。該市場涵蓋用於破壞細胞膜以釋放和分離細胞成分的技術和產品。該市場對於研究和診斷應用至關重要，能夠實現精細的細胞分析。生物技術的進步和對個人化醫療日益成長的需求推動了對高效、精準的細胞裂解技術的需求。專注於自動化、擴充性和提高產量的創新正在滿足不斷擴展的生物製藥和學術研究領域的需求。

細胞裂解/細胞分級分離市場正經歷強勁成長，這主要得益於生物技術和生命科學研究的進步。試劑和耗材領域是推動市場成長的主要動力，這主要源自於市場對可靠高效能細胞裂解解決方案的需求。其中，基於洗滌劑的試劑表現最佳，因為它們高效且與多種細胞類型相容。機械破碎方法，例如珠磨和超音波，也因其在大規模應用中的有效性而日益普及。設備同樣發揮重要作用，其中均質機因其精確性和擴充性而佔據主導。自動化細胞分級分離系統也越來越受歡迎，這反映了市場對高通量和可重複結果的需求趨勢。學術和研究機構是最大的終端用戶，這主要得益於對創新研究工具的持續需求。製藥和生物技術公司是第二大成長領域，這主要得益於藥物研發和生產中對先進解決方案的需求。總體而言，技術進步和策略聯盟正在推動市場擴張。

市場區隔
類型	機械破碎、化學破碎、酵素解、熱解、超音波、清潔劑裂解、滲透裂解、凍融
產品	試劑、試劑盒、設備、耗材、緩衝液
科技	離心、流式細胞技術、層析法、電泳、微流體
目的	蛋白質分離、核酸分離、細胞器分離、基於細胞的檢測、藥物發現
最終用戶	製藥公司、生物技術公司、學術研究機構和臨床檢查室
過程	批量處理，連續處理
成分	細胞裂解緩衝液，細胞分級分離緩衝液
裝置	均質機、珠磨機、法式壓榨機、超音波

細胞裂解/細胞分級分離市場呈現動態的市場格局，市場佔有率、定價策略和產品創新都發生顯著變化。現有主要企業不斷推出新產品，以提高細胞分析的效率和準確性。定價策略也在不斷演變，以反映日益激烈的市場競爭和技術進步。自動化和高通量系統的應用尤其值得關注，滿足了市場對快速可靠細胞分析解決方案日益成長的需求。這些趨勢凸顯了激烈的競爭格局，各公司力求透過創新和策略聯盟實現差異化。細胞裂解/細胞分級分離市場的競爭異常激烈，主要廠商透過策略聯盟和技術進步爭奪市場優勢。法規結構，尤其是在北美和歐洲，確保了合規性和安全性，並對市場動態產生重大影響。基準分析表明，專注於研發和永續發展的企業正在獲得競爭優勢。在生物技術進步及其在臨床和研究領域應用不斷擴展的推動下，該市場呈現出成長動能。儘管監管合規和技術整合等挑戰依然存在，但新興市場和個人化醫療領域蘊藏著許多機會。

主要趨勢和促進因素：

細胞裂解/細胞分級分離市場正經歷強勁成長，主要受生物技術和藥物研發進步的推動。關鍵趨勢包括個人化醫療的興起（需要精準的細胞分析）以及慢性疾病數量的增加（需要創新療法）。研發領域的巨額投資也推動了先進細胞裂解技術的應用。生物製藥產業的擴張是推動市場成長的主要因素，該產業需要高效的細胞分離和分析方法來簡化藥物研發流程。此外，隨著研究人員致力於揭示細胞機制，對癌症研究的日益重視也推動了對細胞分級分離工具的需求。實驗室工作流程自動化也是推動因素之一，提高了細胞裂解/細胞分級分離的效率和準確性。新興市場蘊藏著巨大的機遇，不斷成長的醫療保健支出和基礎設施建設推動了先進生物技術工具的應用。提供經濟高效且擴充性解決方案的公司有望獲得競爭優勢。此外，學術機構和產業參與者之間的合作正在促進最尖端科技的開發，為細胞裂解/細胞分級分離市場的未來成長鋪平道路。

市場規模及預測：依類型
- 機械破壞
- 化學壓裂
- 酵素解
- 熱熔法
- 超音波
- 基於清潔劑的裂解方法
- 滲透溶解
- 凍融法
市場規模及預測：依產品分類
- 試劑
- 成套工具
- 裝置
- 消耗品
- 緩衝溶液
市場規模及預測：依技術分類
- 離心
- 流式細胞技術
- 層析法
- 電泳
- 微流體技術
市場規模及預測：依應用領域分類
- 蛋白質分離
- 核酸分離
- 細胞器分離
- 基於細胞的檢測
- 藥物發現
市場規模及預測：依最終用戶分類
- 製藥公司
- 生技公司
- 學術研究機構
- 臨床檢查室
市場規模及預測：依製程分類
- 批量處理
- 連續加工
市場規模及預測：依組件分類
- 細胞裂解緩衝液
- 細胞分級緩衝液
市場規模及預測：依設備分類
- 均質機
- 珠磨機
- 法式濾壓壺
- 超音波處理設備

第5章區域分析

北美洲
- 美國
- 加拿大
- 墨西哥
拉丁美洲
- 巴西
- 阿根廷
- 其他拉丁美洲地區
亞太地區
- 中國
- 印度
- 韓國
- 日本
- 澳洲
- 台灣
- 亞太其他地區
歐洲
- 德國
- 法國
- 英國
- 西班牙
- 義大利
- 其他歐洲地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 南非
- 撒哈拉以南非洲
- 其他中東和非洲地區

第6章市場策略

需求與供給差距分析
貿易和物流限制
價格、成本和利潤率趨勢
市場滲透率
消費者分析
法規概述

第7章競爭訊息

市場定位
市場占有率
競爭基準
主要企業的策略

第8章公司簡介

Merck Millipore
Thermo Fisher Scientific
Bio-Rad Laboratories
QIAGEN
Promega Corporation
New England Biolabs
Takara Bio
Roche Applied Science
Agilent Technologies
Perkin Elmer
Illumina
Beckman Coulter
Eppendorf
Abcam
Sartorius
GE Healthcare Life Sciences
BD Biosciences
Lonza Group
Gen Script
Cell Signaling Technology

第9章：關於我們

簡介目錄

Product Code: GIS20804

Cell Lysis/Cell Fractionation Market is anticipated to expand from $4.5 billion in 2024 to $8.0 billion by 2034, growing at a CAGR of approximately 5%. The Cell Lysis/Cell Fractionation Market encompasses technologies and products designed to break down cell membranes to release and isolate cellular components. This market is vital for research and diagnostic applications, enabling detailed cellular analysis. With advancements in biotechnology and increased demand for personalized medicine, there is a growing need for efficient, precise cell lysis techniques. Innovations focus on automation, scalability, and enhanced yield, catering to the expanding biopharmaceutical and academic research sectors.

The Cell Lysis/Cell Fractionation Market is experiencing robust growth, propelled by advancements in biotechnology and life sciences research. The reagents and consumables segment dominates, driven by the need for reliable and efficient cell lysis solutions. Among these, detergent-based reagents are top-performing, offering high efficiency and compatibility with various cell types. Mechanical disruption methods, such as bead milling and sonication, follow closely, favored for their effectiveness in large-scale applications. Instruments also play a pivotal role, with homogenizers leading due to their precision and scalability. Automated cell fractionation systems are gaining prominence, reflecting the trend towards high-throughput and reproducible results. The academic and research institutions segment is a key end-user, given the continuous demand for innovative research tools. Pharmaceutical and biotechnology companies are the second-highest performing segment, driven by the need for advanced solutions in drug development and production. Overall, technological advancements and strategic collaborations are fostering market expansion.

Market Segmentation
Type	Mechanical Disruption, Chemical Disruption, Enzymatic Lysis, Thermal Lysis, Sonication, Detergent-Based Lysis, Osmotic Lysis, Freeze-Thaw Lysis
Product	Reagents, Kits, Instruments, Consumables, Buffers
Technology	Centrifugation, Flow Cytometry, Chromatography, Electrophoresis, Microfluidics
Application	Protein Isolation, Nucleic Acid Isolation, Subcellular Organelle Isolation, Cell-Based Assays, Drug Discovery
End User	Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories
Process	Batch Processing, Continuous Processing
Component	Cell Lysis Buffer, Cell Fractionation Buffer
Device	Homogenizers, Bead Mills, French Press, Ultrasonic Processors

The Cell Lysis/Cell Fractionation Market exhibits a dynamic landscape with significant shifts in market share, pricing strategies, and product innovation. Established players are continuously launching novel products to enhance efficiency and precision in cell analysis. Pricing strategies are evolving, reflecting the competitive intensity and technological advancements within the market. The introduction of automated and high-throughput systems is particularly noteworthy, catering to the increasing demand for rapid and reliable cell analysis solutions. These trends underscore a robust competitive environment, with companies striving to differentiate through innovation and strategic partnerships. Competition within the Cell Lysis/Cell Fractionation Market is fierce, with key players vying for dominance through strategic alliances and technological advancements. Regulatory frameworks, particularly in North America and Europe, significantly influence market dynamics, ensuring compliance and safety. Benchmarking reveals that companies focusing on R&D and sustainable practices are gaining a competitive edge. The market is poised for growth, driven by advancements in biotechnology and increasing applications in clinical and research settings. Challenges such as regulatory compliance and technological integration persist, yet opportunities abound in emerging markets and personalized medicine.

Geographical Overview:

The cell lysis/cell fractionation market is witnessing noteworthy growth across various regions, each exhibiting unique dynamics. North America leads the market due to advanced biotechnology research and significant investments in life sciences. The region's robust infrastructure and innovation in cell-based research further bolster its market dominance. Europe follows, driven by substantial research and development in biotechnology and pharmaceuticals. The region's focus on precision medicine and personalized therapies enhances market growth. In Asia Pacific, the market is expanding rapidly, propelled by increasing investments in biotechnology and healthcare infrastructure. Emerging economies like China and India are at the forefront, offering lucrative opportunities. Latin America and the Middle East & Africa are emerging as promising markets. In Latin America, growing research activities and investments in biotechnology are driving market expansion. Meanwhile, the Middle East & Africa recognize the importance of advancing cell-based research, fostering economic growth and innovation in the region.

The global cell lysis/cell fractionation market is significantly influenced by tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, reliance on imported raw materials and equipment faces tariff-induced cost pressures, prompting strategic shifts towards local production capabilities. China's focus on self-reliance is evident as it invests in domestic biotechnological advancements to mitigate export restrictions. Taiwan, with its robust biotech sector, remains pivotal but is geopolitically sensitive due to US-China tensions. The parent market, encompassing biotechnology and pharmaceuticals, is experiencing robust growth driven by innovation and increased demand for personalized medicine. By 2035, the market's trajectory will hinge on resilient supply chains and strategic regional collaborations. Middle East conflicts pose indirect risks by potentially escalating energy costs, thereby impacting production expenses globally.

Key Trends and Drivers:

The Cell Lysis/Cell Fractionation Market is experiencing robust growth, primarily driven by advancements in biotechnology and pharmaceutical research. Key trends include the rise of personalized medicine, which demands precise cellular analysis, and the increasing prevalence of chronic diseases, necessitating innovative therapeutic solutions. The market is also witnessing significant investments in research and development, fostering the introduction of technologically advanced cell lysis techniques. Drivers of this market include the expanding biopharmaceutical sector, which requires efficient cell separation and analysis methods to enhance drug discovery processes. Additionally, the growing focus on cancer research is propelling the demand for cell fractionation tools, as researchers seek to understand cellular mechanisms better. The integration of automation in laboratory workflows is another driver, improving efficiency and accuracy in cell lysis and fractionation. Opportunities are abundant in emerging markets, where increased healthcare spending and infrastructure development are encouraging the adoption of advanced biotechnological tools. Companies that innovate in providing cost-effective and scalable solutions are likely to gain a competitive edge. Furthermore, collaborations between academic institutions and industry players are fostering the development of cutting-edge technologies, paving the way for future growth in the Cell Lysis/Cell Fractionation Market.

Research Scope:

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by End User
2.6 Key Market Highlights by Process
2.7 Key Market Highlights by Component
2.8 Key Market Highlights by Device

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Mechanical Disruption
- 4.1.2 Chemical Disruption
- 4.1.3 Enzymatic Lysis
- 4.1.4 Thermal Lysis
- 4.1.5 Sonication
- 4.1.6 Detergent-Based Lysis
- 4.1.7 Osmotic Lysis
- 4.1.8 Freeze-Thaw Lysis
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Reagents
- 4.2.2 Kits
- 4.2.3 Instruments
- 4.2.4 Consumables
- 4.2.5 Buffers
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 Centrifugation
- 4.3.2 Flow Cytometry
- 4.3.3 Chromatography
- 4.3.4 Electrophoresis
- 4.3.5 Microfluidics
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Protein Isolation
- 4.4.2 Nucleic Acid Isolation
- 4.4.3 Subcellular Organelle Isolation
- 4.4.4 Cell-Based Assays
- 4.4.5 Drug Discovery
4.5 Market Size & Forecast by End User (2020-2035)
- 4.5.1 Pharmaceutical Companies
- 4.5.2 Biotechnology Companies
- 4.5.3 Academic and Research Institutes
- 4.5.4 Clinical Laboratories
4.6 Market Size & Forecast by Process (2020-2035)
- 4.6.1 Batch Processing
- 4.6.2 Continuous Processing
4.7 Market Size & Forecast by Component (2020-2035)
- 4.7.1 Cell Lysis Buffer
- 4.7.2 Cell Fractionation Buffer
4.8 Market Size & Forecast by Device (2020-2035)
- 4.8.1 Homogenizers
- 4.8.2 Bead Mills
- 4.8.3 French Press
- 4.8.4 Ultrasonic Processors

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Application
  - 5.2.1.5 End User
  - 5.2.1.6 Process
  - 5.2.1.7 Component
  - 5.2.1.8 Device
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Application
  - 5.2.2.5 End User
  - 5.2.2.6 Process
  - 5.2.2.7 Component
  - 5.2.2.8 Device
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Application
  - 5.2.3.5 End User
  - 5.2.3.6 Process
  - 5.2.3.7 Component
  - 5.2.3.8 Device
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Application
  - 5.3.1.5 End User
  - 5.3.1.6 Process
  - 5.3.1.7 Component
  - 5.3.1.8 Device
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Application
  - 5.3.2.5 End User
  - 5.3.2.6 Process
  - 5.3.2.7 Component
  - 5.3.2.8 Device
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Application
  - 5.3.3.5 End User
  - 5.3.3.6 Process
  - 5.3.3.7 Component
  - 5.3.3.8 Device
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Application
  - 5.4.1.5 End User
  - 5.4.1.6 Process
  - 5.4.1.7 Component
  - 5.4.1.8 Device
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Application
  - 5.4.2.5 End User
  - 5.4.2.6 Process
  - 5.4.2.7 Component
  - 5.4.2.8 Device
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Application
  - 5.4.3.5 End User
  - 5.4.3.6 Process
  - 5.4.3.7 Component
  - 5.4.3.8 Device
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Application
  - 5.4.4.5 End User
  - 5.4.4.6 Process
  - 5.4.4.7 Component
  - 5.4.4.8 Device
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Application
  - 5.4.5.5 End User
  - 5.4.5.6 Process
  - 5.4.5.7 Component
  - 5.4.5.8 Device
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Application
  - 5.4.6.5 End User
  - 5.4.6.6 Process
  - 5.4.6.7 Component
  - 5.4.6.8 Device
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Application
  - 5.4.7.5 End User
  - 5.4.7.6 Process
  - 5.4.7.7 Component
  - 5.4.7.8 Device
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Application
  - 5.5.1.5 End User
  - 5.5.1.6 Process
  - 5.5.1.7 Component
  - 5.5.1.8 Device
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Application
  - 5.5.2.5 End User
  - 5.5.2.6 Process
  - 5.5.2.7 Component
  - 5.5.2.8 Device
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Application
  - 5.5.3.5 End User
  - 5.5.3.6 Process
  - 5.5.3.7 Component
  - 5.5.3.8 Device
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Application
  - 5.5.4.5 End User
  - 5.5.4.6 Process
  - 5.5.4.7 Component
  - 5.5.4.8 Device
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Application
  - 5.5.5.5 End User
  - 5.5.5.6 Process
  - 5.5.5.7 Component
  - 5.5.5.8 Device
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Application
  - 5.5.6.5 End User
  - 5.5.6.6 Process
  - 5.5.6.7 Component
  - 5.5.6.8 Device
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Application
  - 5.6.1.5 End User
  - 5.6.1.6 Process
  - 5.6.1.7 Component
  - 5.6.1.8 Device
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Application
  - 5.6.2.5 End User
  - 5.6.2.6 Process
  - 5.6.2.7 Component
  - 5.6.2.8 Device
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Application
  - 5.6.3.5 End User
  - 5.6.3.6 Process
  - 5.6.3.7 Component
  - 5.6.3.8 Device
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Application
  - 5.6.4.5 End User
  - 5.6.4.6 Process
  - 5.6.4.7 Component
  - 5.6.4.8 Device
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Application
  - 5.6.5.5 End User
  - 5.6.5.6 Process
  - 5.6.5.7 Component
  - 5.6.5.8 Device

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Merck Millipore
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Thermo Fisher Scientific
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Bio- Rad Laboratories
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 QIAGEN
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Promega Corporation
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 New England Biolabs
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 Takara Bio
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Roche Applied Science
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Agilent Technologies
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Perkin Elmer
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Illumina
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Beckman Coulter
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Eppendorf
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Abcam
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Sartorius
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 GE Healthcare Life Sciences
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 BD Biosciences
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Lonza Group
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Gen Script
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Cell Signaling Technology
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis